ALI TEHRANI is listed as an executive officer and director on 13 SEC Form D filings by 2 issuers between Jul 2009 and Oct 2019: Zymeworks Inc. (Vancouver, British Columbia, Canada (as filed: A1) — biotechnology — 2009–2016; $61.5M reported sold to 31 investors) and Creatus Biosciences Inc. (Vancouver, British Columbia, Canada (as filed: A1) — biotechnology — 2017–2019; $218K reported sold to 2 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 10 years. Across those companies the filings report $61.7M sold in total.
Listed alongside NEIL KLOMPAS (13 shared filings), Noel Hall (13 shared filings), HAIG FARRIS (12 shared filings), Kenneth Galbraith (11 shared filings), Nick Bedford (11 shared filings) and 15 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around ALI. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 13 public filings for ALI TEHRANI and found 8 differences, 2 worth asking the sponsor about: Amount sold went down between filings; Form D filed 860 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.